Africa CDC presses donors as Ebola tool gaps sharpen
Thursday, August 27, 2026 · 6 min
Africa CDC and regional leaders are pressing donors to move Ebola funds faster into DRC response work, while new Bundibugyo vaccine-serology data underscores how uncertain the medical-tool picture remains.
Listen
Show notes
Africa CDC and regional leaders are pressing donors to move Ebola funds faster into DRC response work, while new Bundibugyo vaccine-serology data underscores how uncertain the medical-tool picture remains.
In this episode
- African Leaders Call For Faster Funding, As DRC Ebola Outbreak Spreads | Science Nigeria — Science Nigeria
African Leaders Call For Faster Funding, As DRC Ebola Outbreak Spreads | Science Nigeria Search Search = More… Search # African Leaders Call For Faster Funding, As DRC Ebola Outbreak Spreads August 25, 2026 1 ### Report Calls For Stronger Private Sector Role In Malaria Control Report Calls For Stronger Private Sector Role In Malaria Control August 25, 2026 ### NITDA Unveils Taskforce…
- Step Back — With more than 1,000 Ebola deaths now reported in the DRC, why might vaccines and treatments still fail to prevent so many deaths—and what can health officials learn from vaccination, contact-tracing, and treatment-center data about where the response is breaking down?
Background sources
- As DR Congo Ebola outbreak tops 5,500 cases, calls for more resources intensify | CIDRAP — CIDRAP
- Vaccine preparedness for Bundibugyo virus and lessons learned | npj Vaccines — npj Vaccines
- First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial — Oxford Vaccine Group — Ox
- Bundibugyo Ebola virus outbreak: launch of the EBO-PEP trial to protect high-risk contacts - EBO-PEP — Céline Rouger
- EXPLAINER | How the DRC’s Ebola outbreak became the second most lethal on record — Reuters Agency
- [Articles] Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus–Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort study – Science Feed — Science Feed
[Articles] Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus–Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort study – Science Feed The differing patterns of BDBV glycoprotein seroreactivity observed between Beni and Mbandaka warrant further investigation into the…